IQVIA Holdings (IQV) PT Raised to $290 at Mizuho Securities

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. ABBV
4. LITE
5. CL
6. LYB
7. TFII
8. SPY
9. AAPL
10. NVT

Go back to IQVIA Holdings (IQV) PT Raised to $290 at Mizuho Securities

IQVIA Holdings (IQV) Added to BofA US1 List, Medtronic (MDT) Removed

November 18, 2021 5:57 AM EST

IQVIA Holdings (NYSE: IQV) Added to BofA US1 List, Medtronic (NYSE: MDT) Removed

... More

IQVIA Holdings (IQV) PT Raised to $261 at Piper Sandler

November 18, 2021 4:52 AM EST

Piper Sandler analyst Sean Wieland raised the price target on IQVIA Holdings (NYSE: IQV) to $261.00 (from $250.00) while maintaining a Neutral rating.... More

IQVIA Holdings (IQV) PT Raised to $310 at UBS

November 17, 2021 10:01 AM EST

UBS analyst Dan Brennan raised the price target on IQVIA Holdings (NYSE: IQV) to $310.00 (from $298.00) while maintaining a Buy rating.... More

IQVIA Holdings (IQV) PT Raised to $309 at Jefferies

November 17, 2021 7:52 AM EST

Jefferies analyst David Windley raised the price target on IQVIA Holdings (NYSE: IQV) to $309.00 (from $300.00) while maintaining a Buy rating.

The analyst commented, "We anticipated raises in medium-term guidance metrics, but got more than we expected. Organic rev at +9% midpoint is 1% more... More

IQVIA Holdings (IQV) PT Raised to $313 at Stifel

November 17, 2021 7:07 AM EST

Stifel analyst Shlomo Rosenbaum raised the price target on IQVIA Holdings (NYSE: IQV) to $313.00 (from $304.00) while maintaining a Buy rating.

The analyst commented, "We continue to like the IQV story, and believe the analyst day supports our positive thesis on the shares. The 2022... More

IQVIA Holdings (IQV) PT Raised to $320 at BofA Securities

November 17, 2021 6:02 AM EST

BofA Securities analyst Derik de Bruin raised the price target on IQVIA Holdings (NYSE: IQV) to $320.00 (from $290.00) while maintaining a Buy rating.... More

IQVIA Holdings (IQV) PT Raised to $290 at KeyBanc

November 17, 2021 4:32 AM EST

KeyBanc analyst Donald Hooker raised the price target on IQVIA Holdings (NYSE: IQV) to $290.00 (from $270.00) while maintaining a Overweight rating.... More

NRx Pharmaceuticals (NRXP) Reports Q3 Net Loss of $20.8M; Provides Clinical and Financial Update

November 16, 2021 5:57 AM EST

NRx Pharmaceuticals (Nasdaq: NRXP), a clinical-stage, biopharmaceutical company, today provided a business update and financial results for the quarter ended September 30, 2021. NRx will host a conference call Tuesday morning, November 16th, at 8:30 AM Eastern Time to discuss its business update and third-quarter financial results.

Investors and the general public are invited to listen to a live audio webcast of the conference call, which may be accessed five minutes before the start of the call by dialing (877) 705-6003 (U.S.), (201) 493-6725 (International) Conference ID: 13724953, or through the webcast link... More